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SUMMARY 
Cavum septum pellucidum (CSP) and cavum Vergae 
(CV) are unusual variants and usually asymptomatic, 
but their expansion or inside lesions can produce symp-
toms by mass effect. A 46-year-old female Taiwanese 
worker presented with chronic daily headaches for 
eight years. Magnetic resonance imaging revealed co-
existent CSP and CV. She declined surgical drainage 
recommended by a neurosurgeon and thus visited our 
clinic for a second opinion. Physical examination did 
not show any abnormality. With the help of the pa-
tient’s one-month headache diary, she was diagnosed 
with chronic migraine according to the International 
Classification of Headache Disorders, 2nd edition, with 
further modification in 2006. In addition, hypertension 
was also identified. Over the following week, taking a 
daily selective β1-antagonist relieved the headache and 
hypertension. The medication was continued and the 
following year was uneventful. Therefore, the chronic 
daily headache was ascribed to chronic migraine, rather 
than symptomatic CSP and CV. 
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INTRODUCTION 
The cavum septum pellucidum (CSP) is defined as a 
crevice-like space of variable width between the left 
and right transparent septum. If CSP extends posterior-
ly above the third ventricle and is bounded by the sple-
nium posteriorly, it is called a cavum Vergae (CV), 1 
which is defined as a horizontal cleft between the 
commisura fornicis (or psalterium) and the corpus cal-
losum. 2  
 
CSP and CV are normal incident variants and are 
sometimes called the 5th and 6th cerebral ventricles. 3 
These are now incorrect as the cava is apart from the 
adjacent ventricles and does not have normal ependy-
mal lining or choroid plexus cells. 4  
 
A review of 1,000 computed tomographies of British 
boxers showed that CSP had a prevalence of 5.5%; 
both CSP and CV occurred at a rate of 0.5%. 3 In a re-
view of 9,074 Chinese computed tomographies, CSP 
had a prevalence of 0.51%; CV had a prevalence of 
0.08%, and cases of coexistent CSP and CV account 
for 0.65%. 5  
 
Apparently, coexistent CSP and CV has been consid-
ered an unusual curiosity in the literature published 
over ten years ago, but such incidental findings are not 
uncommon in currently day-to-day radiology. In 2009, 
we encountered such a patient with chronic daily head-
ache, which comprises a group of headache disorders 
where the headache occurs at a frequency greater than 
15 days per month and lasts more than four hours per 
day over a three months period, and the prevalence is 
about 4% to 5% in the general Taiwan population. 6  
 
This compelled us to discuss whether or not the neuro-
radiological finding accounted for the clinical symp-
toms in the unusual patient.  
 
CASE REPORT 
A 46-year-old female Taiwanese worker with a height 
of 171 cm, a body weight of 60 kg and a body mass 
index of 20.5 kg/m2, did not suffer from diabetic melli-
tus, heart disease or other systemic diseases. She did 
not smoke cigarettes, drink alcohol or consume areca 
nut, but drank one cup (250 mL) of coffee every morn-
ing.  
 
She has been bothered with daily headache since 2001. 
All kinds of non-steroidal anti-inflammatory drugs 
failed to provide relief, and even dihydroergotamine 
(5mg) could not reverse the course. On May 2009, she 
visited our hospital where magnetic resonance imaging 
(1.5 Tesla system, Picker Edge Eclipse, Picker 98 In-
ternational, USA) demonstrated CSP, 18.2×8.9mm 
(Figure, arrow-head 1), and CV, 32.8×5.5mm, with 
inside cavum velum interpositum (Figure, arrow-head 
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2). Symptomatic CSP and CV were suspected and sur-
gical drainage was recommended by a neurosurgeon, 
but she declined.  
 
 
Figure 1 Magnetic resonance scan of patient’s brain 
 
Then, she visited our clinic for a second opinion. Neu-
rological and otorhinolaryngologic physical examina-
tions did not show any remarkable abnormality. When 
she was symptomatic, the blood pressure was 141/86 
mmHg with a heart rate of 67/min. Then, she was in-
vited to fill in a one-month headache diary and record 
blood pressure daily.  
 
Over the following month, the average blood pressure 
was 141.8±3.3/87.2±3.7 (average±SD) mmHg with an 
average heart rate of 65.8±2.1/min. The headache diary 
(Table 1) revealed she had daily mild-to-moderate left 
throbbing hemi-cephalalgia, and twelve attacks ful-






Date 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
The degree of headache (1=mild 2=moderate 3=severe) 
Morning 1 1 1 1 1 1 1 1 2 2 1 1  1 1 1 1 1 1 1 2 1 1 1 2 1 1 1 1 1 
Afternoon 2 2 1 2 2 1 2 2 1 2 1 1      1  1 2 2 2 1 2 2 2 2 2 2 
Evening 2 2 1 1 1    1 2 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 
Sleep time 2 1 1 1 1    1 1    1 1              2 2 
Symptom accompanied, please mark “√” 
Nausea √ √ √ √     √ √ √     √ √ √ √  √   √ √ √ √  √ √ 
Vomiting                               
Photophobia √ √ √ √ √ √ √ √ √  √ √  √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
Phonophobia √ √  √          √ √ √ √ √ √ √ √ √ √ √ √ √  √  √ 
Throbbing 
pain 
√ √ √ √ √    √   √ √ √ √     √ √   √ √ √ √ √ √ √ 
Unilateral 
headache* 
√ √ √   √ √   √ √   √ √     √ √   √ √  √ √ √ √ 
Activity in-
tolerance 
√ √ √ √ √    √ √ √          √   √ √ √ √ √ √ √ 
Paresthesia** √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
Aura, please mark “√” 
Flash light                               
Visual field 
defect 
√ √ √ √   √                        
Attack duration (hour) 
 24 12 10 8 8 2 2 4 8 8 8 4 2 2 2 2 3 3 4 6 8 5 6 8 8 12 12 12 18 24 
Analgesics and the dose 
 Daily four tablet of acetaminophen 500mg and four tablets of ibuprofen 400mg 
The effect of analgesics (0=none 1=some effect 2=good effect 3=very good effect) 
 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Period of menses, please mark “√” 
 √ √ √ √                        √ √ √ 
Table 1 A 30-day diary of episodes of headaches 
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This interfered with her work and life, and could be 
exacerbated by exercise and head rotation. The accom-
panied symptoms were dysarthria, blurred vision, nau-
sea, vomiting, phonophobia, photophobia and hemi-
facial paraesthesia. Headaches began in the morning, 
peaked at noon and remitted in the afternoon out the 
time of menstruation, but remitted till sleep at the time 
of menstruation. The daily symptomatic duration was 
7.8±5.8 hours.  
 
According to the International Classification of Head-
ache Disorders, 2nd edition, with further modification in 
2006 (ICHD-IIR),7 she was diagnosed with chronic 
migraine and hypertension. Therefore, a daily 0.25 
tablet of selective β1-antagonist atenolol (100mg) was 
recommended. Over the following week, the headache 
with accompanied symptoms did not recur. The weekly 
average blood pressure was 123/77 mmHg with an 
average heart rate of 63/min. Thus long-term therapy 
with a daily 25mg tablet of atenolol was continued. 
The following year was uneventful. 
  
DISCUSSION 
The embryologic origins of CSP and CV differ from 
that of the ventricular system.4 In the fourth embryo-
logic month, a pellucid space develops in the pellucid 
septum and is expected to degenerate in the infant 
stage, but a few cases persist as they grow, resulting in 
CSP and/or CV.5 CSP and/or CV are usually asympto-
matic but may be occasionally symptomatic.  
 
There have been studied in relation to headaches, sei-
zures, dementia, personality changes, and schizophre-
nia. 5,8 Additionally, expansion or inside lesions of the 
cava can produce symptoms by distorting the vessels, 
compressing the hypothalamo-septal triangle, or com-
pressing the optic pathways. 1,9,10 Fenestration to the 
lateral ventricles, cystoventriculoatrial shunts or cysto-
peritoneal shunts have been recommended in sympto-
matic cases because spontaneous regressions have only 
occurred in three cases reported in the literature. 1,12-14 
 
The width of CSP is between 6 mm and 20 mm, and 
that of CV is between 6 mm and 19 mm. 5 The width of 
the patient’s CSP was within the usual range, but that 
of the CV was smaller than the usual range; therefore, 
the size of the cava was unlikely to become sympto-
matic by mass effect, and the neurosurgeon’s opinion 
was controversial. However, the non-observed expand-
ing of the cava had potential to become causative, and 
the neurosurgeon’s opinion merited consideration. 
 
 In order to make a convincing diagnosis and to clarify 
the doubt, it was necessary to know what sort of head-
ache the patient was suffering from. We suggested that 
she write a structured headache diary.  
This method has been widely used in research and clin-
ical practice to provide full-view prospective data that 
may not be noticed retrospectively.  
 
According to the ICHD-IIR, chronic migraine is con-
firmed if the chronic daily headache fulfils the follow-
ing four criteria: 7  
(A) headache (tension-type and/or migraine) on at least 
15 days per month for at least three months,  
(B) occurring in a patient who has had at least five at-
tacks fulfilling criteria for migraine without aura,  
(C) headaches on at least eight days/month for at least 
three months, fulfilling C1 and/or C2, that is, meeting 
criteria for pain and associated symptoms of migraine 
without aura. C1 has at least two of the below factors: 
unilateral location, pulsating quality, moderate or se-
vere pain intensity, aggravated by or caused by routine 
physical activity (e.g. walking or climbing stairs), nau-
sea and/or vomiting, photophobia and phonophobia. C2 
is treatable and relieved by triptan(s) or ergot before 
the expected development of C1 above,  
(D) no medication overuse is present and it is not at-
tributed to another causative disorder.  
 
With the help of the patient’s headache diary (Table), 
she was thus diagnosed with chronic migraine by 
matching the criteria A, B, C, C1 and D.  
 
Dihydroergotamine mesylate is a migraine-specific 
agent15 but it failed to cure her. Preventive medication 
is recommended for chronic migraine. The first is β-
antagonist, followed by anti-depressants, calcium 
channel blockers, anticonvulsants, or others, in order to 
improve the sufferer’s life quality and lower the cere-
bral and cardiovascular risk. 16  
 
Since hypertension was concomitantly present, a selec-
tive β1-antagonist was recommended and just 25 mg 
per day to control her hypertension and cure the chron-
ic migraine over the following week. The medication 
was continued and the following year was uneventful. 
Therefore, the chronic daily headache was ascribed to 
chronic migraine, rather than symptomatic CSP and 
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